Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
Mallinckrodt
Queensland Health
Teva
Argus Health
Cerilliant
US Department of Justice
Julphar

Generated: July 17, 2018

DrugPatentWatch Database Preview

Latanoprost - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for latanoprost and what is the scope of latanoprost patent protection?

Latanoprost
is the generic ingredient in three branded drugs marketed by Akorn, Amring Pharms, Apotex Inc, Bausch And Lomb, Dr Reddys Labs Ltd, Fdc Ltd, Mylan, Sandoz Inc, and Pharmacia And Upjohn, and is included in ten NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for latanoprost. Fifteen suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for latanoprost
Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog
Synonyms for latanoprost
(15R)-Latanoprost
(1R,2R,3R,5S,3''R)-7-[3,5-Dihydroxy-2-(3-hydroxy-5-phenyl-pentyl)-cyclopentyl]-hept-5-enoic acid isopropyl ester
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptanoic acid 1-methylethyl ester
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid propan-2-yl ester
(Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate
130209-82-4
155551-81-8
209L824
33537-EP2295409A1
33537-EP2311820A1
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-, 1-methylethyl ester
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-, 1-methylethyl ester, (1R-(1-alpha(Z),2-beta(R*),3-alpha,5-alpha))-
6Z5B6HVF6O
A806039
AB00640005-04
AB00640005-06
AB2000019
ABP001061
AC1NSK8Q
AKOS024458331
Ambap130209-82-4
AR-202
AT-3016
BDBM50240648
C26H40O5
Catioprost
CCG-100946
CHEBI:6384
CHEMBL1051
CPD000466354
CS-2758
D00356
D0C6NM
DB00654
DTXSID1041057
GAAP Ofteno
GGXICVAJURFBLW-CEYXHVGTSA-N
GTPL1961
HMS2051H11
HMS2089J17
HY-B0577
Isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate
isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate
Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate
Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
Isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate
Isopropyl-(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate
J-005764
Jsp001835
L-PPDS
L0262
L1167_SIGMA
latanoprost (isopropyl ester)
Latanoprost (JAN/USAN/INN)
Latanoprost [USAN:INN:BAN]
latanoprost free acid
Latanoprost, (+/-)-
Latanoprost, >=98% (HPLC), oil
Latanoprost, United States Pharmacopeia (USP) Reference Standard
latanoprostum
MFCD00216074
MLS000759468
MLS001424106
MolPort-003-942-862
NC00196
NCGC00246969-01
Nova-21027
PhXA 41
PHXA-41
PhXA34 [as 15(R,S)-isomer]
PhXA41
propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-bis(oxidanyl)-2-[(3R)-3-oxidanyl-5-phenyl-pentyl]cyclopentyl]hept-5-enoate
propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
s4709
SAM001246671
SC-18987
SCHEMBL24698
SMR000466354
ST24047444
T-2345
TL8000716
Tris(2,4-dimethylphenyl)phosphine-5,5',5""""-trisulfonic acid trisodium salt
UNII-6Z5B6HVF6O
UNII-8S5FB3XXG8 component GGXICVAJURFBLW-CEYXHVGTSA-N
XA 41
XA-41
XA41
Xalatan
Xalatan (TN)
ZINC12468792
Tentative approvals for LATANOPROST
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up0.005%SOLUTION; OPHTHALMIC

US Patents and Regulatory Information for latanoprost

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amring Pharms LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 200925-001 Mar 22, 2011 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb VYZULTA latanoprostene bunod SOLUTION/DROPS;OPHTHALMIC 207795-001 Nov 2, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Mylan LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 201786-001 Mar 22, 2011 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 202077-001 Feb 11, 2013 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for latanoprost

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Cantor Fitzgerald
Argus Health
Accenture
Healthtrust
Federal Trade Commission
Johnson and Johnson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.